NICE Ltd And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) – NICE Ltd (NICE), NBT Bancorp (NBTB), ResMed (RMD) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. NICE Ltd (NICE)

14.8% sales growth and 10.56% return on equity

NICE Ltd., together with its subsidiaries, provides cloud platforms for AI-driven digital business solutions worldwide. It offers CXone, a cloud native open platform; Enlighten, an AI engine for the customer engagement market; and smart self service enable organizations to address consumers' needs; and journey orchestration solutions that empower organizations to connect and route customers to deal with the customer's request, and connects them using real time AI-based routing. The company provides smart self service solutions that empower organizations to build intelligent automated conversations based on data; and prepared agent solutions and tools enable contact center agents to guide and alert them in real time; provides solutions that help organizations to record structured and unstructured customer interaction and transaction data; and NICE Evidencentral, an digital evidence management platform for public safety emergency communications, law enforcement, and criminal justice helps agencies. In addition, it offers X-Sight, is an open and flexible AI-cloud platform for financial crime and compliance; Xceed, a cloud platform for comprehensive AML and fraud prevention for small and mid-sized organizations; data intelligence solutions that enable organizations to turn raw data into comprehensive actionable intelligence to prevent and detect financial crimes; AI and analytics technologies to detect and prevent financial crimes in real-time; money laundering and fraud prevention solutions that help organizations adhere to capital markets compliance and anti-money laundering compliance regulations; intelligent investigations solutions; and self-service solutions that provide organizations with customization and self-development capabilities. The company was formerly known as NICE-Systems Ltd. and changed its name to NICE Ltd. in June 2016. NICE Ltd. was founded in 1986 and is headquartered in Ra'anana, Israel.

Earnings Per Share

As for profitability, NICE Ltd has a trailing twelve months EPS of $5.11.

PE Ratio

NICE Ltd has a trailing twelve months price to earnings ratio of 47.13. Meaning, the purchaser of the share is investing $47.13 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.56%.

Moving Average

NICE Ltd’s worth is above its 50-day moving average of $219.13 and way above its 200-day moving average of $199.32.

Revenue Growth

Year-on-year quarterly revenue growth grew by 9.6%, now sitting on 2.38B for the twelve trailing months.

Yearly Top and Bottom Value

NICE Ltd’s stock is valued at $240.82 at 11:22 EST, below its 52-week high of $253.00 and way above its 52-week low of $149.54.

Earnings Before Interest, Taxes, Depreciation, and Amortization

NICE Ltd’s EBITDA is 62.55.

2. NBT Bancorp (NBTB)

9.6% sales growth and 9.14% return on equity

NBT Bancorp Inc., a financial holding company, provides commercial banking, retail banking, and wealth management services. Its deposit products include demand deposit, savings, negotiable order of withdrawal, money market deposit, and certificate of deposit accounts. The company's loan portfolio comprises commercial and industrial, commercial real estate, agricultural, and commercial construction loans; indirect and direct consumer, home equity, mortgages, business banking loans, and commercial loans; and residential real estate loans. It also provides trust and investment services; financial planning and life insurance services; and retirement plan consulting and recordkeeping services. In addition, the company offers insurance products comprising personal property and casualty, business liability, and commercial insurance, as well as other products and services through 24-hour online, mobile, and telephone channels that enable customers to check balances, make deposits, transfer funds, pay bills, access statements, apply for loans, and access various other products and services. As of December 31, 2020, it had 141 branches and 176 ATMs in New York, Pennsylvania, Vermont, Massachusetts, New Hampshire, and Maine. NBT Bancorp Inc. was founded in 1856 and is headquartered in Norwich, New York.

Earnings Per Share

As for profitability, NBT Bancorp has a trailing twelve months EPS of $2.65.

PE Ratio

NBT Bancorp has a trailing twelve months price to earnings ratio of 13.42. Meaning, the purchaser of the share is investing $13.42 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.14%.

Yearly Top and Bottom Value

NBT Bancorp’s stock is valued at $35.57 at 11:22 EST, way below its 52-week high of $43.77 and way above its 52-week low of $27.53.

Volume

Today’s last reported volume for NBT Bancorp is 510090 which is 167.82% above its average volume of 190454.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on Feb 29, 2024, the estimated forward annual dividend rate is 1.28 and the estimated forward annual dividend yield is 3.6%.

Moving Average

NBT Bancorp’s value is above its 50-day moving average of $35.54 and above its 200-day moving average of $35.36.

3. ResMed (RMD)

6.5% sales growth and 21.66% return on equity

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. It operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. The company was founded in 1989 and is headquartered in San Diego, California.

Earnings Per Share

As for profitability, ResMed has a trailing twelve months EPS of $6.04.

PE Ratio

ResMed has a trailing twelve months price to earnings ratio of 31.66. Meaning, the purchaser of the share is investing $31.66 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.66%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

ResMed’s EBITDA is 6.42.

4. Global Payments (GPN)

5.5% sales growth and 4.44% return on equity

Global Payments Inc. provides payment technology and software solutions for card, check, and digital-based payments in the Americas, Europe, and the Asia-Pacific. It operates through two segments, Merchant Solutions and Issuer Solutions. The Merchant Solutions segment offers authorization, settlement and funding, customer support, chargeback resolution, terminal rental, sales and deployment, payment security, and consolidated billing and reporting services. This segment also provides an array of enterprise software solutions that streamline business operations of its customers in various vertical markets; and value-added solutions and services, such as point-of-sale software, analytics and customer engagement, payroll and reporting, and human capital management. The Issuer Solutions segment offers solutions that enable financial institutions and retailers to manage their card portfolios through a platform; and commercial payments, account payables, and electronic payment alternatives solutions for businesses and governments. It markets its products and services through direct sales force, trade associations, agent and enterprise software providers, referral arrangements with value-added resellers, and independent sales organizations. The company was founded in 1967 and is headquartered in Atlanta, Georgia.

Earnings Per Share

As for profitability, Global Payments has a trailing twelve months EPS of $3.77.

PE Ratio

Global Payments has a trailing twelve months price to earnings ratio of 33.45. Meaning, the purchaser of the share is investing $33.45 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.44%.

Sales Growth

Global Payments’s sales growth is 6% for the present quarter and 5.5% for the next.

Moving Average

Global Payments’s worth is below its 50-day moving average of $131.88 and higher than its 200-day moving average of $118.45.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Global Payments’s EBITDA is 5.05.

Volume

Today’s last reported volume for Global Payments is 155468 which is 93.32% below its average volume of 2330610.

Leave a Reply

Your email address will not be published. Required fields are marked *